Sorry, your browser doesn't suppor Java.
                        HIV- Management                         Page 2 
   

In HIV infection there is intense and persistent viral replication which leads to gradual depletion of CD4 cells. The primary goal in managing the HIV patients is to prevent this process of replication to as low as possible and to to maintain it as long as possible.  With this there is lower risk of clinical progression of the disease and prevention of opportunistic infection. 

Classes of ANTIRETROVIRAL DRUGS

Anti retroviral drugs act by inhibiting the multiplication of the virus. Currently available drugs target 2 key enzymes the the virus requires to multiply. These are PROTEASE and REVERSE TRASCRIPTASE. Drugs inhibiting the Reverse Transcriptase enzyme are divided into two types - Neucleoside Reverse Transcriptase Inhibitors (NRTIs) & Non-Neucleoside Reverse Transcriptase Inhibitors (NNRTIs).  

Combination Therapy

HIV virus has the ability of developing resistance if any one drug is used alone. Hence current guidlines are to use at least 3 antiretroviral drugs in combination. This is the same principle used in the treatment of tuberculosis. This triple drug regime is commonly called HAART ( Highly Active Antiretoviral Therapy). HAART has been shown to inhibit viral replication to levels below the limit of detection.  

 

Initiating Antiretroviral Therapy

The antiretroviral therapy is started in persons with sign of compromised immune system or indication of presence of Opportunistic infection.
CH4+ cell count less than 500 cells/ micoliter or increase of viral load to more than 5,000 - 10,000 copies/ milliliter. are indications of reduced immune strength.

All symptomatic patients with symptoms suggestive of active infection - wasting, thrush or unexplained fever for > 2 wks. should be started with antiretroviral drugs irrespective of the viral load. 

Proper counseling of the patients is also very important before commencing the therapy. Patients should be told about the fats that the therapy has to be life long and it is not curative. Cost of the therapy and side effects should be known to the patient. Adherence to the treatment process should be thoroughly stressed. The patient should know that even if he or she is keeping fine transmission of the infection to others is possible and safe sex methods should be practiced.   

 

Commonly used initial Antiretroviral regimens

Antiretroviral drug regimens are comprised of one choice each from column A and B. 

Column A

Column B

Efavirenz Stavudine + Didanosine
Indinavir Stavudine + Lamivudine
Nelfinavir Zidovudine + Lamivudine
Nevirapine Zidovudine + Didanosine
Saquinavir  

 

Page 1

  Antiretroviral Drugs available in Indian subcontitent

New Anti HIV Drug Amprenavir

HIV Infection

HIV Pathogenesis

HIV Management

HIV Update

Manbir Singh